Albania vs Tonga: Tuberculosis patients living with HIV receiving antiretroviral therapy
Albania
1 patients
in 2021
Tonga
1 patients
in 2021
Albania rank
130th
Tonga rank
130th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Albania
- Tonga
How they compare
Albania currently reports 1 patients against 1 patients in Tonga, a difference of 0 patients.
The two have swapped places 3 times across 16 shared years of data; in 2006 it was Albania ahead.
Albania ranks 130th and Tonga ranks 130th of 183 countries.
Albania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Albania | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.5 patients | 0 patients | 3.5 patients | Albania |
| 2010s | 4.3 patients | 0 patients | 4.3 patients | Albania |
| 2020s | 1.5 patients | 0.5 patients | 1 patients | Albania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Albania or Tonga?
- Albania, at 1 patients against 1 patients in Tonga as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Albania and Tonga?
- 0 patients, with Albania ahead.
- How many years of comparable data are there for Albania and Tonga?
- 16 years are reported by both, from 2006 to 2021.
- How do Albania and Tonga rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Albania ranks 130th and Tonga ranks 130th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.